Delivery Order 75N95024D00012-75N95024F00002
Award Date
9/30/24
Potential Completion Date
9/29/26
Potential Value
$796K
Funding Federal Agency
National Center for Advancing Translational Sciences
Contracting Federal Agency
National Institute on Drug Abuse
Awardee
Mriglobal
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Kansas City, MO 64110, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $5,108,214.00 cost-plus-award-fee delivery order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Mriglobal, doing business as Midwest Research Institute, a 501(c)(3) not-for-profit research organization. The contract is part of the Drug Manufacturing and Formulation Program (DMFP) with an ultimate completion date of September 18, 2029. Mriglobal has been awarded multiple significant federal contracts and grants, including Indefinite Delivery Contracts...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a definitive contract valued at $21.88 million to MRIGlobal for the Mycobacterium tuberculosis Quality Assessment Program. Under this cost-plus-fixed-fee contract holding one base year and six option periods extending through November 2030, MRIGlobal will support laboratories conducting clinical trials on tuberculosis. Services will include proficiency...
This is a $26,932,208.00 cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute, a civilian agency, to Mriglobal, doing business as Midwest Research Institute, a 501(c)(3) not-for-profit research organization. The contract is for a Centralized Chemopreventive Agent Repository and Chemistry Support and has an ultimate completion date of June 30, 2028. Mriglobal is the prime contractor and there is no set-aside designation indicated. The contract appears to be part of...
This is a Cost Plus Fixed Fee contract awarded by the National Cancer Institute to Mriglobal, a 501(c)(3) not-for-profit research organization based in Kansas City, Missouri. The contract, valued at $1,658,742.83, is for drug shelf life testing services. The contract does not have a set-aside designation. Mriglobal has significant experience as a prime contractor for the federal government, holding multiple Indefinite Delivery Vehicles (IDVs) with various agencies such as the National...
This is a $25,543,276.37 cost-plus-fixed-fee definitive contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to the not-for-profit research organization Mriglobal (doing business as Midwest Research Institute). The contract is for the analysis of anti-cancer chemicals and pharmaceutical formulations. Mriglobal is a highly experienced federal contractor, holding several significant...
This is a $114,038 cost-plus-fixed-fee delivery order awarded to Mriglobal, a 501(c)(3) not-for-profit research organization, by the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services. The delivery order is for contract management support activities under the BIO-AMT-2301 Indefinite Delivery/Indefinite Quantity (IDIQ) contract. No set-aside was used for this award. Mriglobal, which does business as Midwest Research...
This is a $4,415,116.56 cost-plus-fixed-fee contract awarded by the National Cancer Institute (NCI), part of the Department of Health and Human Services (HHS), to Mriglobal, doing business as Midwest Research Institute, to provide shelf life evaluation of investigational dosage forms. The contract does not have a small business set-aside designation. Mriglobal is an independent, not-for-profit research organization that conducts over $110 million in research annually for federal and commercial...
This is a delivery order federal contract awarded by the National Cancer Institute, a civilian agency under the Department of Health and Human Services, to Mriglobal, doing business as Midwest Research Institute, a 501(c)(3) not-for-profit research organization. The $1,524,929.00 contract is for the manufacture of plasmid DNA drug substance and drug product. The period of performance runs through September 24, 2027. Mriglobal has been awarded multiple significant federal contracts and grants...
This is a Cost Plus Award Fee delivery order under a $1,283,149.00 contract awarded by the National Institute of Neurological Disorders and Stroke, a civilian agency, to Mriglobal (also known as Midwest Research Institute), a 501(c)(3) not-for-profit research organization. The contract is part of the Drug Manufacturing and Formulation Program (DMFP) master IDIQ, and the task is for the PADERI HEAL PROJECT-IHP-102. There is no set-aside designation for this award. Mriglobal is the prime...
This task order was awarded by the National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to Mriglobal, doing business as Midwest Research Institute, a not-for-profit research organization. The task order, valued at $131,421.00, is for analytical method development and validation, characterization, and stability studies of the drug substance ML-246 under the parent contract "CRO Support for NCATS Drug Substance Development and Manufacture." The...